These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 3299097)
1. The Federal regulation of medical devices. Kessler DA; Pape SM; Sundwall DN N Engl J Med; 1987 Aug; 317(6):357-66. PubMed ID: 3299097 [No Abstract] [Full Text] [Related]
3. More coverage for new devices urged. Gardner J Mod Healthc; 1994 Sep; 24(38):23. PubMed ID: 10136453 [No Abstract] [Full Text] [Related]
4. Are you ready? FDA final rules on devices are on the way. Berek B Health Facil Manage; 1996 Sep; 9(9):56, 58, 60 passim. PubMed ID: 10160028 [No Abstract] [Full Text] [Related]
5. Medical devices. Part I. A primer on medical device regulation. Drew G FDA Consum; 1986 May; 20(4):24-7. PubMed ID: 10311540 [No Abstract] [Full Text] [Related]
7. The financing and regulation of medical devices in the United States. Sisk JE Med Prog Technol; 1982; 9(2-3):181-6. PubMed ID: 7162490 [TBL] [Abstract][Full Text] [Related]
8. Medical devices. Part II. The Medical Device Amendments 10 years after. Interview by William Rados. Villforth J FDA Consum; 1986 May; 20(4):28-32. PubMed ID: 10311541 [No Abstract] [Full Text] [Related]
9. HHS probe stirs device controversy. Scott L Mod Healthc; 1994 Jul; 24(28):54. PubMed ID: 10135039 [No Abstract] [Full Text] [Related]
10. Medicare and Medicaid programs; quarterly listing of program issuances--first quarter, 1998--HCFA. Notice. Fed Regist; 1998 Sep; 63(179):49598-605. PubMed ID: 10185191 [TBL] [Abstract][Full Text] [Related]
11. Diffusion of new technologies. Can Medicare payment decisions be made faster and more efficiently? VanAntwerp M J Health Care Technol; 1985; 2(2):97-103. PubMed ID: 10300492 [No Abstract] [Full Text] [Related]
12. Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain. Chambers JD; May KE; Neumann PJ Health Aff (Millwood); 2013 Jun; 32(6):1109-15. PubMed ID: 23733986 [TBL] [Abstract][Full Text] [Related]
13. Medicare program; replacement of reasonable charge methodology by fee schedules for parenteral and enteral nutrients, equipment, and supplies. Final rule. Centers for Medicare & Medicaid Services (CMS), HHS Fed Regist; 2001 Aug; 66(167):45173-7. PubMed ID: 11757567 [TBL] [Abstract][Full Text] [Related]
14. New obstacles in the path of marketing new medical devices. Bucci VA; Reiss JB; Hall NC J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491 [TBL] [Abstract][Full Text] [Related]
15. Postmarketing surveillance of medical devices using Medicare claims. Malenka DJ; Kaplan AV; Sharp SM; Wennberg JE Health Aff (Millwood); 2005; 24(4):928-37. PubMed ID: 16012135 [TBL] [Abstract][Full Text] [Related]
17. Medicare; limitations on reimbursement of nonphysician medical services--HCFA. Correction of final rule. Fed Regist; 1986 Apr; 51(65):11582. PubMed ID: 10300684 [TBL] [Abstract][Full Text] [Related]
18. Medical devices; medical device reporting. Direct final rule. Food and Drug Administration, HHS Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310 [TBL] [Abstract][Full Text] [Related]
19. Industry effects of medical device regulation: the case of diagnostic imaging equipment. McKay NL J Policy Anal Manage; 1986; 6(1):35-44. PubMed ID: 10279385 [TBL] [Abstract][Full Text] [Related]
20. HCFA wrestles problem of DME coinsurance waivers. Beck E Med Prod Sales; 1984 Jun; 15(6):1, 59-62. PubMed ID: 10324843 [No Abstract] [Full Text] [Related] [Next] [New Search]